NCT04198116View on ClinicalTrials.gov

Combining Varenicline and Guanfacine for Smoking Cessation

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline

Varenicline 2mg/day

DRUG

Guanfacine ER

Guanfacine Extended Release (6mg/day ER)

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT04198116 - Combining Varenicline and Guanfacine for Smoking Cessation | Biotech Hunter | Biotech Hunter